Benefits of sunlight: Vitamin D deficiency might increase the risk of sudden unexpected death in epilepsy

Medical Hypotheses

Volumn 74, Issue 1, 2010, Pages 158-161

  Scorza, Fulvio A ^a   Albuquerque, Marly de ^a   Arida, Ricardo M ^a   Terra, Vera C ^b   Machado, Hélio R ^b   Cavalheiro, Esper A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTICONVULSIVE AGENT; CALBINDIN; CALCITRIOL RECEPTOR; COD LIVER OIL; COLECALCIFEROL; ERGOCALCIFEROL; PARVALBUMIN; PLACEBO; VITAMIN D RECEPTOR;

ANTICONVULSANT ACTIVITY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; EPILEPSY; EPILEPTIC DISCHARGE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SEIZURE; SUDDEN DEATH; SUN EXPOSURE; SUNLIGHT; VITAMIN D DEFICIENCY;

ANIMALS; ANTICONVULSANTS; DEATH, SUDDEN, CARDIAC; EPILEPSY; HUMANS; MICE; MODELS, BIOLOGICAL; MODELS, THEORETICAL; RISK; RISK FACTORS; SEIZURES; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 70450230480     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.07.009     Document Type: Article

References (54)

1. de Boer H.M., Mula M., and Sander J.W. The global burden and stigma of epilepsy. Epilepsy Behav 12 (2008) 540-546
2. Sander J.W. The epidemiology of epilepsy revisited. Curr Opin Neurol 16 (2003) 165-170
3. Kwan P., and Sander J.W. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 75 (2004) 1376-1381
4. Hirsch L.J., and Hauser W.A. Can sudden unexplained death in epilepsy be prevented?. Lancet 364 (2004) 2157-2158
5. Duncan J.S., Sander J.W., Sisodiya S.M., and Walker M.C. Adult epilepsy. Lancet 367 (2006) 1087-1100
6. Tomson T., Nashef L., and Ryvlin P. Sudden unexpected death in epilepsy: current knowledge and future directions. Lancet Neurol 7 (2008) 1021-1031
7. Spratling WP. Prognosis. In: Epilepsy and its treatment, Philadelphia: W B Saunders; 1904. p. 304.
8. Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 38 (1997) S6-S8
9. Stollberger C., and Finsterer J. Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res 59 (2004) 51-60
10. Schuele S.U., Widdess-Walsh P., Bermeo A., and Lüders H.O. Sudden unexplained death in epilepsy: the role of the heart. Cleve Clin J Med 74 (2007) S121-S127
11. So E.L. What is known about the mechanisms underlying SUDEP?. Epilepsia 49 Suppl. 9 (2008) 93-98
12. Scorza F.A., de Albuquerque M., Arida R.M., and Cavalheiro E.A. Sudden unexpected death in epilepsy: are winter temperatures a new potential risk factor?. Epilepsy Behav 10 (2007) 509-510
13. Scorza F.A., Colugnati D.B., Pansani A.P., Sonoda E.Y., Arida R.M., and Cavalheiro E.A. Preventing tomorrow's sudden cardiac death in epilepsy today: what should physicians know about this?. Clinics 63 (2008) 389-394
14. Ryvlin P., Montavont A., and Kahane P. Sudden unexpected death in epilepsy: from mechanisms to prevention. Curr Opin Neurol 19 (2006) 194-199
15. Apollo. Available from: http://en.wikipedia.org/wiki/Apollo.
16. Mead MN. Benefits of sunlight: a bright spot for human health. Environ Health Perspect 2008;116: A160-7.
17. McCollum E.V., and Davis M. The necessity of certain lipins in the diet during growth. J Biol Chem 25 (1913) 167-231
18. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80 (2004) 1689S-1696S
19. Velluz L, Amiard G. Chimie organique-equilibre de réaction entre précalciférol et calciférol. (The organic chemical equilibrium of the reaction between precalciferol and calciferol.) C R Assoc Anat 1949;228:853-5.
20. Lee J.H., O'Keefe J.H., Bell D., Hensrud D.D., and Holick M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 52 (2008) 1949-1956
21. Matsuoka L.Y., Ide L., Wortsman J., MacLaughlin J.A., and Holick M.F. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 64 (1987) 1165-1168
22. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 92 (2006) 39-48
23. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
24. Murphy B.P., Stanton T., and Dunn F.G. Hypertension and myocardial ischemia. Med Clin North Am 93 3 (2009 May) 681-695
25. Scragg R., Sowers M., and Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the third national health and nutrition examination survey. Am J Hypertens 20 (2007) 713-719
26. Martins D., Wolf M., Pan D., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the third national health and nutrition examination survey. Arch Intern Med 167 (2007) 1159-1165
27. Forman J.P., Giovannucci E., Holmes M.D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49 (2007) 1063-1069
28. Li Y.C. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 88 (2003) 327-331
29. Krause R., Bühring M., Hopfenmüller W., Holick M.F., and Sharma A.M. Ultraviolet B and blood pressure. Lancet 352 (1998) 709-710
30. Simpson R.U., Hershey S.H., and Nibbelink K.A. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 103 (2007) 521-524
31. Bodyak N., Ayus J.C., Achinger S., Shivalingappa V., Ke Q., Chen Y.S., et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci 104 (2007) 16810-16815
32. Chen S., Glenn D.J., Ni W., et al. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension 52 (2008) 1106-1112
33. Tishkoff D.X., Nibbelink K.A., Holmberg K.H., Dandu L., and Simpson R.U. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes. VDR knock. Endocrinology 149 (2008) 558-564
34. Pilz S., and Tomaschitz A. Vitamin D deficiency and myocardial dysfunction. J Am Coll Cardiol 53 (2009) 2011
35. Zittermann A., and Koerfer R. Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metab Care 11 (2008) 752-757
36. Zittermann A., Fischer J., Schleithoff S.S., Tenderich G., Fuchs U., and Koerfer R. Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors. Int J Vitam Nutr Res 77 (2007) 280-288
37. Zittermann A., and Koerfer R. Protective and toxic effects of vitamin D on vascular calcification: clinical implications. Mol Aspects Med 29 (2008) 423-432
38. Grasse F., Sanchis P., Perello J., Isern B., Prieto R.M., Fernandez Palomeque C., et al. Effect of crystallization inhibitors on vascular calcifications induced by vitamin D - a pilot study in Sprague-Dawley rats. Circ J 71 (2007) 1152-1156
39. Ali F.E., Al-Bustan M.A., Al-Busairi W.A., and Al-Mulla F.A. Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann Pharmacother 38 (2004) 1002-1005
40. Christiansen C., Rodbro P., and Sjö O. "Anticonvulsant action" of vitamin D in epileptic patients? A controlled pilot study. Br Med J 2 (1974) 258-259
41. Offermann G., Pinto V., and Kruse R. Antiepileptic drugs and vitamin D supplementation. Epilepsia 20 (1979) 3-15
42. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., and WionD. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metabol 13 (2002) 100-105
43. Kalueff A.V., Eremin K.O., and Tuohimaa P. Mechanisms of neuroprotective actions of vitamin D3. Biochemistry 69 (2004) 907-911
44. Leranth C., and Ribak C.E. Calcium-binding proteins are concentrated in the CA2 field of the monkey hippocampus: a possible key to this region's resistance to epileptic damage. Exp Brain Res 85 (1991) 129-136
45. Kalueff A.V., Minasyan A., Keisala T., Kuuslahti M., Miettinen S., and Tuo-himaa P. Increased severity of chemically induced seizures in mice with partially deleted vitamin D receptor gene. Neurosci Lett 394 (2006) 69-73
46. Janjoppi L., Katayama M.H., Scorza F.A., Folgueira M.A., Brentani M., Pansani A.P., et al. Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine. Brain Res Bull 76 (2008) 480-484
47. Holick M.F. Vitamin D: a D-Lightful health perspective. Nutr Rev 66 (2008) S182-S194
48. Holick M.F. Vitamin D: a millennium perspective. J Cell Biochem 88 (2003) 296-307
49. Holick M.F. Phylogenetic and evolutionary aspects of vitamin D from phytoplankton to humans. In: Pang P.K.T., and Schreibman M.P. (Eds). Vertebrate endocrinology: fundamentals and biomedical implications vol. 3 (1989), Academic Press, Orlando, FL 7-43
50. Tomson T., Walczak T., Sillanpaa M., and Sander J.W. Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia 46 11 (2005) 54-61
51. Dietary supplement fact sheet: Vitamin D. Office of Dietary Supplements, NIH Clinical Center, National Institutes of Health. 2007. Available at: . [accessed 30.06.09].
52. Gaby A.R. Natural approaches to epilepsy. Altern Med Rev 12 (2007) 9-24
53. Scorza F.A., Cysneiros R.M., Arida R.M., Terra-Bustamante V.C., de Albuquerque M., and Cavalheiro E.A. The other side of the coin: beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav 13 (2008) 279-283
54. Bell G.S., and Sander J.W. Sudden unexpected death in epilepsy. Risk factors, possible mechanisms and prevention: a reappraisal. Acta Neurol Taiwan 15 (2006) 72-83